<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of benign breast diseases</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of benign breast diseases</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview of benign breast diseases</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael S Sabel, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anees B Chagpar, MD, MSc, MA, MPH, MBA, FACS, FRCS(C)</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gary J Whitman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 23, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Benign breast disease represents a spectrum of disorders that come to clinical attention because of patient symptoms (such as breast pain), palpable lesions or other findings on physical examination, or as imaging abnormalities. Following establishment of a benign diagnosis, treatment in general is aimed at symptomatic relief and patient education.</p><p>Some benign breast diseases, such as atypical hyperplasia or lobular carcinoma in situ, confer an increase in the patient's future risk of developing breast cancer and should lead to counseling about screening recommendations and risk reduction strategies. These lesions are considered as risk markers, rather than as premalignant lesions, because those cancers that subsequently develop are not necessarily in the area of the atypia and may occur in the contralateral breast.</p><p>This topic will review the pathologic classification and treatment of benign breast disorders; proliferative lesions with atypia are discussed in more detail in a separate topic. (See  <a class="medical medical_review" href="/d/html/743.html" rel="external">"Atypia and lobular carcinoma in situ: High-risk lesions of the breast"</a>.)</p><p>The evaluation of women presenting with symptoms related to the breast and the diagnosis of breast disorders are discussed separately. (See  <a class="medical medical_review" href="/d/html/802.html" rel="external">"Nipple discharge"</a> and  <a class="medical medical_review" href="/d/html/803.html" rel="external">"Breast pain"</a> and  <a class="medical medical_review" href="/d/html/804.html" rel="external">"Clinical manifestations, differential diagnosis, and clinical evaluation of a palpable breast mass"</a>.)</p><p>Neoplastic diseases of the breast are discussed in other topics. (See  <a class="medical medical_review" href="/d/html/744.html" rel="external">"Clinical features, diagnosis, and staging of newly diagnosed breast cancer"</a> and  <a class="medical medical_review" href="/d/html/14219.html" rel="external">"Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H1789157272"><span class="h1">EPIDEMIOLOGY AND RISK FACTORS</span><span class="headingEndMark"> — </span>The risk of benign breast diseases is associated with age and hormonal factors: </p><p class="headingAnchor" id="H4130103807"><span class="h2">Age</span><span class="headingEndMark"> — </span>In a retrospective study of over 61,000 Swedish women, hyperplasia without atypia, fibrocystic changes, and fibroadenomas were quite common at younger ages, increasing during the 30s and 40s and then decreasing thereafter (<a class="graphic graphic_figure graphicRef132022" href="/d/graphic/132022.html" rel="external">figure 1</a>) [<a href="#rid1">1</a>]. The peak incidence is typically in the mid-40s. The incidence rates for other benign lesions, such as adenosis, papillomas, or nonepithelial tumors, were much lower.</p><p class="headingAnchor" id="H1040483600"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Benign breast diseases are impacted by several risk factors, though heterogenously [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Obesity is generally associated with a reduced premenopausal risk of benign breast diseases, with the exception of hyperplasia without atypia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>No association has been reported between the age of menarche and the risk of benign breast diseases, and the impact of irregular menstrual cycles has been inconsistently reported. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Oral contraceptives are generally protective against benign breast diseases, especially with longer duration of use, whereas hormone replacement increases the risk of benign breast diseases. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A family history of breast cancer has been associated with an increased risk of benign breast diseases, predominantly at premenopausal ages. </p><p></p><p>A study of 68,132 postmenopausal women found that recreational physical activity after menopause was associated with a lower risk of having benign proliferative epithelial breast lesions. The risk was reduced by 6 percent for every 5 metabolic equivalent hours/week increase between baseline and year 3 [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H2"><span class="h1">CLASSIFICATION OF BENIGN BREAST LESIONS</span><span class="headingEndMark"> — </span>Benign epithelial breast lesions can be classified histologically into three categories: nonproliferative, proliferative without atypia, and atypical hyperplasia. The categorization is based upon the degree of cellular proliferation and atypia [<a href="#rid3">3-12</a>]. (See  <a class="medical medical_review" href="/d/html/812.html" rel="external">"Breast development and morphology"</a>.) </p><p class="headingAnchor" id="H3"><span class="h1">NONPROLIFERATIVE LESIONS</span><span class="headingEndMark"> — </span>Nonproliferative epithelial lesions are generally not associated with an increased risk of breast cancer [<a href="#rid3">3</a>]. It should be noted that terms such as fibrocystic changes, fibrocystic disease, chronic cystic mastitis, and mammary dysplasia refer to nonproliferative lesions and are not useful clinically, as they encompass a heterogeneous group of diagnoses [<a href="#rid7">7,13</a>]. </p><p>The most common nonproliferative breast lesions are breast cysts. Other nonproliferative lesions include galactoceles, papillary apocrine change, epithelial-related calcifications, and mild hyperplasia of the usual type [<a href="#rid7">7</a>]. Apocrine metaplasia (also referred to as a "benign epithelial alteration") is also a nonproliferative change that is secondary to some form of irritation, typically associated with a breast cyst.</p><p class="headingAnchor" id="H4"><span class="h2">Simple breast cysts</span><span class="headingEndMark"> — </span>Fifty percent of women will experience a noncancerous breast lump at some point in their lives; approximately one-quarter of these lesions are cysts. Breast cysts are fluid-filled, round, or ovoid masses derived from the terminal duct lobular unit. Breast cysts can present as breast masses or as mammographic abnormalities. Cysts are common in women between 35 and 50 years old. Acute enlargement of cysts may cause severe, localized pain of sudden onset. The diagnosis and management of breast cysts is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/799.html" rel="external">"Breast cysts: Clinical manifestations, diagnosis, and management"</a>.)</p><p class="headingAnchor" id="H3249676536"><span class="h2">Galactocele</span><span class="headingEndMark"> — </span>Galactoceles (milk retention cysts) are cystic collections of fluid, usually caused by an obstructed milk duct. These present as soft cystic masses on physical examination. At mammography, galactoceles may appear as indeterminate masses, unless the classic fat-fluid levels are seen. Ultrasound may show a complex mass. The diagnosis can be made based on the clinical history and aspiration, which yields a milky substance [<a href="#rid14">14</a>]. Once the diagnosis is established, excision is not necessary, and there is no increased risk of subsequent breast cancer. (See  <a class="medical medical_review" href="/d/html/4996.html" rel="external">"Common problems of breastfeeding and weaning"</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Papillary apocrine change</span><span class="headingEndMark"> — </span>Papillary apocrine change is a proliferation of ductal epithelial cells showing apocrine features, characterized by eosinophilic cytoplasm [<a href="#rid7">7</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Mild hyperplasia of the usual type</span><span class="headingEndMark"> — </span>Mild hyperplasia of the usual type is an increase in the number of epithelial cells within a duct that is more than two, but not more than four, cells in depth [<a href="#rid7">7</a>]. The epithelial cells do not cross the lumen of the involved space.</p><p class="headingAnchor" id="H8"><span class="h1">PROLIFERATIVE LESIONS WITHOUT ATYPIA</span><span class="headingEndMark"> — </span>Proliferative lesions without atypia include usual ductal hyperplasia, intraductal papillomas, sclerosing adenosis, radial scars, adenomas, fibroadenomas, and pseudoangiomatous stromal hyperplasia. These lesions can be associated with a small increased risk of developing breast cancer, approximately 1.5 to 2 times that of the general population [<a href="#rid4">4-7,10,11,15-18</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Usual ductal hyperplasia</span><span class="headingEndMark"> — </span>Ductal hyperplasia without atypia is a pathologic diagnosis, usually found as an incidental finding on biopsy of mammographic abnormalities or breast masses, characterized by an increased number of cells within the ductal space. Although the cells vary in size and shape, they retain the cytological features of benign cells [<a href="#rid7">7,8</a>]. No treatment is needed for ductal hyperplasia. The risk of subsequent breast cancer in women with usual ductal hyperplasia is small, and chemoprevention is not indicated.</p><p class="headingAnchor" id="H10"><span class="h2">Intraductal papillomas</span><span class="headingEndMark"> — </span>Intraductal papillomas consist of a monotonous array of papillary cells that grow from the wall of a cyst into its lumen. Although they are not concerning in and of themselves, they can harbor areas of atypia or ductal carcinoma in situ (DCIS). Papillomas can occur as solitary or multiple lesions.</p><p class="headingAnchor" id="H3174906479"><span class="h3">Solitary lesions</span><span class="headingEndMark"> — </span>Solitary intraductal papillomas may be identified as a mass on mammography (<a class="graphic graphic_diagnosticimage graphicRef83703" href="/d/graphic/83703.html" rel="external">image 1</a>), ultrasound (<a class="graphic graphic_diagnosticimage graphicRef83702" href="/d/graphic/83702.html" rel="external">image 2</a>), magnetic resonance imaging (MRI) (<a class="graphic graphic_diagnosticimage graphicRef85531" href="/d/graphic/85531.html" rel="external">image 3</a>), or ductography [<a href="#rid19">19</a>], or they can be found incidentally [<a href="#rid20">20</a>]. Nipple discharge, particularly bloody nipple discharge, is a frequent clinical presentation. (See  <a class="medical medical_review" href="/d/html/802.html" rel="external">"Nipple discharge", section on 'Pathologic (suspicious) nipple discharge'</a>.) </p><p class="bulletIndent1"><span class="glyph">●</span>When a core biopsy demonstrates a papilloma with atypical cells, surgical excision is warranted [<a href="#rid17">17,21-26</a>]. Papillary lesions with atypia are upgraded pathologically up to 67 percent of the time [<a href="#rid24">24,27-29</a>]. After excision, if there is no upgrading beyond atypia, a discussion about endocrine therapy for breast cancer prevention is indicated. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The data surrounding solitary papillomas without evidence of atypia are less clear [<a href="#rid30">30</a>]. Reported rates of upgrade of pure papillary lesions to atypia or malignancy are highly variable, historically ranging from 5 to 20 percent [<a href="#rid21">21,23,26</a>] but trending down to less than 10 percent in the last decade [<a href="#rid20">20,31-35</a>]. Most available data are retrospective, which did not agree on clinical and imaging findings predictive of upgrading at the time of surgery. In a prospective trial by the Translational Breast Cancer Research Consortium (TBCRC) of 116 intraductal papillomas without atypia on core biopsy, excluding discordant findings, the upstage rate on local review was only 1.7 percent [<a href="#rid36">36</a>].</p><p></p><p>The current American Society of Breast Surgeons guidelines suggest individualizing the decision to excise a papilloma based on such criteria as size, symptoms (eg, palpability or nipple discharge), and breast cancer risk factors [<a href="#rid37">37</a>]. Excision is recommended in cases of atypia, a palpable mass lesion, bloody nipple discharge (primarily for symptomatic relief), and/or pathology-imaging discordance, whereas small incidental benign solitary papillomas without atypia and with imaging concordance may be offered close clinical and imaging follow-up. </p><p class="headingAnchor" id="H11"><span class="h3">Multiple lesions</span><span class="headingEndMark"> — </span>Diffuse papillomatosis (multiple papillomas) may present as breast masses or nodules on ultrasound or may be the cause of nipple discharge and can be seen on ductography. Diffuse papillomatosis is defined as a minimum of five papillomas within a localized segment of breast tissue and can be definitively managed with excision [<a href="#rid23">23,38,39</a>]. The risk of subsequent breast cancer in women with diffuse papillomatosis is not well defined but may be higher than with solitary papillomas [<a href="#rid40">40,41</a>]. In one retrospective study, the risk for subsequently developing cancer evaluated in a cohort of patients with papillomas (n = 480) was compared with the risk within the general population [<a href="#rid21">21</a>]. The presence of multiple papillomas without atypia was associated with a relative risk (RR) of 3.01 (95% CI 1.10-6.55). In the presence of atypia, the RR was even greater (RR 7.01, 95% CI 1.97-17.97) [<a href="#rid21">21</a>]. </p><p class="headingAnchor" id="H12"><span class="h2">Sclerosing adenosis</span><span class="headingEndMark"> — </span>Sclerosing adenosis is a lobular lesion with increased fibrous tissue and interspersed glandular cells. It can present as a mass or a suspicious finding on mammography [<a href="#rid42">42,43</a>]. The risk of subsequent breast cancer in those with sclerosing adenosis is about twofold that in the general population [<a href="#rid44">44</a>]. Currently, no treatment, chemoprevention, or enhanced screening is recommended for sclerosing adenosis in the absence of atypia. </p><p class="headingAnchor" id="H13"><span class="h2">Radial scars</span><span class="headingEndMark"> — </span>Radial scars, also called complex sclerosing lesions, are a pathologic diagnosis, usually discovered incidentally when a breast mass or radiologic abnormality is removed or biopsied. Occasionally, radial scars are large enough to be detected on mammography as suspicious spiculated masses, which cannot be reliably differentiated from spiculated carcinomas by imaging alone [<a href="#rid45">45-48</a>]. Radial scars are characterized microscopically by a fibroelastic core with radiating ducts and lobules.</p><p>In general, surgical excision is recommended when radial scars or complex sclerosing lesions are diagnosed on core biopsy, based on series showing that 8 to 17 percent of surgical specimens at subsequent excision are positive for malignancy [<a href="#rid49">49-56</a>]. These high upgrade rates have led to the suggestion that these lesions may actually be premalignant lesions, progressing from scar to hyperplasia to carcinoma [<a href="#rid57">57</a>]. This, however, is controversial, and more contemporary series suggest the presence of undiagnosed cancer is much lower, with upgrade rates in the range of 0.6 to 3.6 percent [<a href="#rid58">58-60</a>]. The upgrade rate is even lower with large-volume (eg, vacuum-assisted) needle biopsy. In a meta-analysis of over 3000 patients with radial scars, the upgrade rate after vacuum-assisted biopsy to invasive and in situ cancer was only 0 and 1 percent, respectively [<a href="#rid61">61</a>]. In a study of 50 patients with radial scars who were followed by active surveillance, no patient progressed on interval imaging at 16 months [<a href="#rid62">62</a>].</p><p>The current recommendations from the American Society of Breast Surgeons state that most radial scars "should be excised, although imaging follow-up is reasonable for small, image-detected radial scars that are completely removed or well-sampled with large-gauge devices and in the setting of imaging-pathology concordance" [<a href="#rid37">37</a>].</p><p>No additional treatment beyond excision is needed for radial scars. The risk of subsequent breast cancer after excision in this population is small, and chemoprevention is not indicated.</p><p class="headingAnchor" id="H14"><span class="h2">Fibroadenomas</span><span class="headingEndMark"> — </span>Fibroadenomas are the most common benign tumor in the breast, accounting for one-half of all breast biopsies. In 20 percent of cases, multiple fibroadenomas occur in the same breast or bilaterally. </p><p>The etiology of fibroadenomas is not known, but a hormonal relationship is likely since they persist during the reproductive years, can increase in size during pregnancy or with estrogen therapy, and usually regress after menopause. They are most commonly found in women between the ages of 15 and 35 years [<a href="#rid63">63</a>].</p><p>Fibroadenomas usually present as well-defined, mobile masses on physical examination or as well-defined solid masses on ultrasound. A well-defined solid mass with imaging features consistent with a fibroadenoma [<a href="#rid64">64</a>] can be managed with core biopsy or short-term (three to six months) follow-up with a repeat ultrasound and breast examination [<a href="#rid65">65</a>]. Definitive diagnosis can only be confirmed with a core biopsy or excision.</p><p>Although originally classified as nonproliferative lesions, fibroadenomas are now considered proliferative breast lesions [<a href="#rid15">15</a>]. However, it is important to note that the histologic features of the fibroadenoma influence the risk of breast cancer. For the majority of women with simple fibroadenomas, there is no increased risk of developing breast cancer [<a href="#rid4">4-7,15</a>]. The risk of subsequent breast cancer is slightly elevated only if there is associated proliferative disease or if there is a significant family history of breast cancer. </p><p class="headingAnchor" id="H3935611844"><span class="h3">Simple fibroadenomas</span><span class="headingEndMark"> — </span>Simple fibroadenomas are benign solid tumors containing glandular as well as fibrous tissue. It is not necessary to excise all biopsy-proven simple fibroadenomas. If a biopsy-proven simple fibroadenoma is asymptomatic, then it can be left in place, although some women wish to have the mass excised so that they will not worry further. Disadvantages of excisional surgery include scarring at the incision site, dimpling of the breast from the removal of the tumor, damage to the breast's duct system, and mammographic changes (eg, architectural distortion, skin thickening, increased focal density). </p><p>Cryoablation is an alternative to surgical excision of simple fibroadenomas but should only be considered after a core biopsy diagnosis of fibroadenoma has been made [<a href="#rid66">66-70</a>]. A multicenter trial of 50 patients who underwent office-based cryoablation under ultrasound guidance reported that the lesions tended to disappear progressively [<a href="#rid67">67</a>], and 75 percent were not palpable at 12 month follow-up [<a href="#rid68">68</a>]. Transient side effects included ecchymosis, local swelling, and discomfort that lasted as long as a few weeks after treatment. Percutaneous vacuum-assisted ultrasound-guided excision is another alternative to open excision technique for removal of fibroadenomas but may be less effective for lesions &gt;2 cm [<a href="#rid71">71</a>].</p><p>If a presumed simple fibroadenoma increases significantly in size or is symptomatic, then excision is mandated to rule out malignant change and confirm the diagnosis [<a href="#rid66">66,67,71</a>]. Rapid growth of a lesion raises the suspicion for a phyllodes tumor. (See  <a class="medical medical_review" href="/d/html/793.html" rel="external">"Phyllodes tumors of the breast"</a>.) </p><p class="headingAnchor" id="H3764235821"><span class="h3">Complex fibroadenomas</span><span class="headingEndMark"> — </span>Complex fibroadenomas present as masses on physical examination or as nodules on mammography or ultrasound. However, on pathology, these contain other proliferative changes, such as sclerosing adenosis, duct epithelial hyperplasia, epithelial calcification, or papillary apocrine changes [<a href="#rid72">72</a>]. They are associated with a slightly increased risk of cancer when multicentric proliferative changes are present in the surrounding glandular tissue. </p><p>Appropriate management of complex fibroadenomas is controversial. While some believe that complex fibroadenomas warrant complete removal for histologic examination, others suggest that they can be managed conservatively following core biopsy [<a href="#rid72">72</a>]. In one series of 401 fibroadenomas, 63 (15.7 percent) were considered complex. At a mean follow-up of two years, invasive carcinoma was found in only 1 of the 63 patients with complex fibroadenomas; her initial core biopsy had shown atypical lobular hyperplasia (ALH).</p><p>There are several factors that increase the suspicion of either phyllodes tumor or future malignancy. These include stromal mitoses, stromal overgrowth, nuclear pleomorphism, fragmentation, adipose tissue infiltration, or other concerns that may be raised by the pathologist. The American Society of Breast Surgeons recommends excision in these cases [<a href="#rid37">37</a>]. </p><p class="headingAnchor" id="H3215215785"><span class="h3">Giant fibroadenomas</span><span class="headingEndMark"> — </span>Giant fibroadenomas refer to histologically typical fibroadenomas over 10 cm in size [<a href="#rid7">7</a>]. Excision is recommended. The primary challenge for the pathologist is to differentiate these from phyllodes tumors. Phyllodes tumors have a more cellular stromal component than fibroadenomas. (See  <a class="medical medical_review" href="/d/html/793.html" rel="external">"Phyllodes tumors of the breast"</a>.)</p><p class="headingAnchor" id="H120576726"><span class="h3">Juvenile fibroadenomas</span><span class="headingEndMark"> — </span>Juvenile fibroadenomas occur in young women between the ages of 10 and 18 years. They may differ in presentation and management from adult fibroadenomas. Juvenile fibroadenoma is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/104.html" rel="external">"Breast masses in children and adolescents", section on 'Fibroadenoma'</a>.)</p><p class="headingAnchor" id="H265811175"><span class="h2">Adenomas</span><span class="headingEndMark"> — </span>Adenomas are pure epithelial neoplasms of the breast. They are distinguished from fibroadenomas by their sparse stromal elements. Adenomas are divided into two main groups: tubular and lactating adenomas. Lactating adenomas occur commonly in pregnancy. They are well circumscribed and lobulated. Although they may require excision because of their size, they do not have malignant potential [<a href="#rid7">7,8</a>]. Tubular adenoma is a rare breast benign neoplasm of young premenopausal women [<a href="#rid73">73</a>]. The imaging or cytologic features are not specific; thus, surgical excision is required to reach a diagnosis by histopathologic analysis [<a href="#rid74">74,75</a>].</p><p class="headingAnchor" id="H1169374893"><span class="h2">Pseudoangiomatous stromal hyperplasia</span><span class="headingEndMark"> — </span>Pseudoangiomatous stromal hyperplasia (PASH) is a benign stromal proliferation that histologically simulates a vascular lesion [<a href="#rid7">7</a>]. PASH may present as a mass or thickening on physical examination. The most common appearance on mammography and ultrasound is a solid, well-defined, noncalcified mass [<a href="#rid76">76</a>].</p><p>The characteristic histologic appearance is a pattern of slit-like spaces in the stroma between glandular units [<a href="#rid77">77</a>]. PASH can be confused with mammary angiosarcoma [<a href="#rid8">8,78</a>].</p><p>If there are any suspicious features on imaging, interval growth, or associated symptoms, the diagnosis of PASH on a core biopsy should not be accepted as a final diagnosis, and excisional biopsy should be performed. However, in the absence of suspicious imaging characteristics, a diagnosis of PASH at core biopsy is considered sufficient, and surgical excision is not always necessary [<a href="#rid79">79,80</a>]. A 2018 Choosing Wisely campaign also advocated avoiding surgical excision in patients with concordant imaging findings and without symptoms [<a href="#rid81">81</a>]. There is no increased risk of subsequent breast cancer associated with PASH.</p><p class="headingAnchor" id="H15"><span class="h1">PROLIFERATIVE LESIONS WITH ATYPIA</span><span class="headingEndMark"> — </span>Proliferative lesions with atypia include atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), and lobular carcinoma in situ (LCIS). These lesions are considered high risk because they are associated with an increase in the patient's future risk of developing breast cancer [<a href="#rid82">82</a>]. Flat epithelial atypia (FEA) is also an atypical proliferation, but this lesion does not appear to convey an elevation in risk beyond that of any associated proliferative lesions present. </p><p>The diagnosis, pathology, and management of patients with ADH, ALH, LCIS, and FEA are discussed in another topic. (See  <a class="medical medical_review" href="/d/html/743.html" rel="external">"Atypia and lobular carcinoma in situ: High-risk lesions of the breast"</a>.)</p><p class="headingAnchor" id="H19"><span class="h1">MISCELLANEOUS BENIGN LESIONS OF THE BREAST</span></p><p class="headingAnchor" id="H20"><span class="h2">Lipoma</span><span class="headingEndMark"> — </span>Breast lipomas are benign, usually solitary tumors composed of mature fat cells. They do not contain histologic elements of breast tissue. These present as soft, nontender, well-circumscribed masses. Clinically, it is sometimes difficult to distinguish lipomas from other conditions; the diagnosis can be confirmed with a core or excisional biopsy. Core biopsies are somewhat problematic for lipomas as it is difficult to be certain that the diagnosis is concordant, and lipomas should be surgically excised if they cause diagnostic confusion, continue to enlarge, or grow rapidly [<a href="#rid8">8</a>]. For smaller lesions, excisional biopsy is often preferable. There is no increased risk of subsequent breast cancer associated with lipomas.</p><p class="headingAnchor" id="H21"><span class="h2">Fat necrosis</span><span class="headingEndMark"> — </span>Fat necrosis of the breast is a benign condition that most commonly occurs as the result of breast trauma or surgical intervention. Fat necrosis can be confused with a malignancy on physical examination and may mimic malignancy on imaging studies [<a href="#rid83">83</a>]. It is sometimes necessary to biopsy these lesions to confirm the diagnosis, although experienced radiologists can usually determine that a lesion represents fat necrosis based on mammographic and ultrasound findings such as oil cysts (collections of liquefied fat) [<a href="#rid8">8,84</a>]. Once the diagnosis is established, excision is not necessary, and there is no increased risk of subsequent breast cancer.</p><p class="headingAnchor" id="H25"><span class="h2">Diabetic mastopathy</span><span class="headingEndMark"> — </span>Diabetic mastopathy is a benign condition that is typically diagnosed in premenopausal (20 to 40 years old) women who have longstanding type 1 diabetes mellitus [<a href="#rid85">85</a>] and associated complications (neuropathy, retinopathy, and nephropathy) [<a href="#rid86">86</a>]. It has also been reported in women with type 2 diabetes and in men [<a href="#rid87">87</a>]. In patients without diabetes, this condition is known as lymphocytic mastitis or lymphocytic mastopathy [<a href="#rid85">85</a>]. Diabetic mastopathy is rare: a 2017 systematic review of 60 studies, mostly case reports, only included 313 patients [<a href="#rid85">85</a>]. The pathogenesis is unknown, but it may represent an autoimmune reaction as the histologic features are similar to those seen in other autoimmune diseases [<a href="#rid88">88</a>]. </p><p>The typical presentation is suspicious breast masses that are hard, poorly demarcated, and movable, but painless [<a href="#rid89">89</a>]. They can be single or multiple, unilateral or bilateral, and can involve all quadrants of the breast, but not the axilla [<a href="#rid90">90,91</a>]. </p><p>Both the clinical features and the imaging characteristics of diabetic mastopathy can mimic those of invasive breast cancer [<a href="#rid92">92</a>]. Thus, multiple imaging studies (ultrasound, mammography, magnetic resonance imaging) may be required to differentiate the two [<a href="#rid89">89</a>]. </p><p>Image-guided core biopsy is recommended for diagnostic confirmation [<a href="#rid93">93</a>]; fine needle biopsy is not feasible, because of the dense fibrosis. Pathology shows dense, keloid-like fibrosis and periductal, lobular, or perivascular lymphocytic infiltration [<a href="#rid94">94-96</a>]. Surgical excision is required if the core biopsy is not conclusive or is not concordant with imaging [<a href="#rid97">97</a>].</p><p>Once the diagnosis of diabetic mastopathy is established, excision is not necessary in asymptomatic patients [<a href="#rid98">98</a>]. Surgical excision can be performed in symptomatic patients [<a href="#rid85">85</a>]. With follow-up, additional lesions may occur, or recur after surgical excision [<a href="#rid85">85</a>]. However, there is only one reported case of invasive breast cancer developing in a patient with diabetic mastopathy [<a href="#rid99">99</a>]. </p><p class="headingAnchor" id="H27"><span class="h2">Hamartoma</span><span class="headingEndMark"> — </span>Hamartomas are benign lesions, also known as fibroadenolipomas, lipofibroadenomas, or adenolipomas [<a href="#rid100">100</a>]. Hamartomas have varying amounts of glandular, adipose, and fibrous tissue. They present as discrete, encapsulated, painless masses or are found incidentally on screening mammography. </p><p>Hamartomas are generally felt to be very rarely associated with cancer, and when cancer is detected it is typically incidental [<a href="#rid101">101</a>]. Thus, most screening-detected hamartomas can be safely observed [<a href="#rid102">102</a>]. However, because hamartomas do not have specific diagnostic features on a core needle biopsy, symptomatic or discordant hamartomas should be surgically excised [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H29"><span class="h2">Idiopathic granulomatous mastitis</span><span class="headingEndMark"> — </span>Idiopathic granulomatous mastitis (IGM) is an inflammatory mass in the breast. The symptoms and imaging findings may be mistaken for nonpuerperal mastitis, a breast abscess, or, most often, carcinoma. Biopsy is necessary to make a diagnosis. IGM is discussed in more detail elsewhere. (See  <a class="medical medical_review" href="/d/html/794.html" rel="external">"Nonlactational mastitis in adults"</a>.)</p><p class="headingAnchor" id="H31"><span class="h2">Sarcoidosis</span><span class="headingEndMark"> — </span>Breast symptomatology in sarcoidosis is rare and seen primarily in patients with systemic involvement. Sarcoidosis of the breast presents as firm, hard masses, mimicking carcinoma. The mammographic appearance is also suspicious with irregular, ill-defined, spiculated masses that are solid on ultrasound. Biopsy is needed for confirmation of the diagnosis [<a href="#rid103">103,104</a>]. There is no increased risk of subsequent breast cancer associated with sarcoidosis of the breast. (See  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis"</a>.)</p><p class="headingAnchor" id="H4128255581"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/121714.html" rel="external">"Society guideline links: Evaluation of breast problems"</a>.)</p><p class="headingAnchor" id="H34"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/8395.html" rel="external">"Patient education: Common breast problems (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H35"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Classification</strong> – Benign epithelial breast lesions can be classified into three categories based on histologic findings: nonproliferative, proliferative without atypia, and proliferative with atypia. (See <a class="local">'Classification of benign breast lesions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nonproliferative lesions</strong> – Nonproliferative lesions are not associated with an increased risk of breast cancer. Management is directed at making a definitive diagnosis and providing relief of symptoms. (See <a class="local">'Nonproliferative lesions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Proliferative lesions</strong> – Proliferative lesions without atypia can be associated with a small increased risk of subsequent breast cancer. Once the diagnosis is established, management is also directed at relieving symptoms. Radial scars, papillomas with atypia, complex fibroadenomas, and any lesion discordant with imaging findings require surgical excision. (See <a class="local">'Proliferative lesions without atypia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Proliferative lesions with atypia</strong> – Proliferative lesions with atypia such as atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), and lobular carcinoma in situ (LCIS) are associated with a substantial increase in risk of subsequent breast cancer. Flat epithelial atypia (FEA) is also an atypical proliferation but does not appear to convey an elevation in cancer risk. The diagnosis and management of these breast lesions are discussed in another topic. (See  <a class="medical medical_review" href="/d/html/743.html" rel="external">"Atypia and lobular carcinoma in situ: High-risk lesions of the breast"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Johansson A, Christakou AE, Iftimi A, et al. Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden. JAMA Netw Open 2021; 4:e2114716.</a></li><li><a class="nounderline abstract_t">Peila R, Chlebowski RT, Ballinger TJ, et al. Physical activity and risk of benign proliferative epithelial disorders of the breast, in the Women's Health Initiative. Int J Epidemiol 2021.</a></li><li><a class="nounderline abstract_t">Schnitt SJ. Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol 2003; 27:836.</a></li><li><a class="nounderline abstract_t">London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992; 267:941.</a></li><li><a class="nounderline abstract_t">Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312:146.</a></li><li><a class="nounderline abstract_t">Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005; 353:229.</a></li><li class="breakAll">Schnitt SJ, Collins LC. Pathology of benign breast disorders. In: Breast Diseases, Harris JR, et al (Eds), Lippincott, 2010. p.69.</li><li><a class="nounderline abstract_t">Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. Oncologist 2006; 11:435.</a></li><li><a class="nounderline abstract_t">Courtillot C, Plu-Bureau G, Binart N, et al. Benign breast diseases. J Mammary Gland Biol Neoplasia 2005; 10:325.</a></li><li><a class="nounderline abstract_t">Is 'fibrocystic disease' of the breast precancerous? Arch Pathol Lab Med 1986; 110:171.</a></li><li><a class="nounderline abstract_t">Page DL, Dupont WD. Anatomic markers of human premalignancy and risk of breast cancer. Cancer 1990; 66:1326.</a></li><li><a class="nounderline abstract_t">Worsham MJ, Abrams J, Raju U, et al. Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Breast J 2007; 13:115.</a></li><li><a class="nounderline abstract_t">Love SM, Gelman RS, Silen W. Sounding board. Fibrocystic "disease" of the breast--a nondisease? N Engl J Med 1982; 307:1010.</a></li><li><a class="nounderline abstract_t">Sabate JM, Clotet M, Torrubia S, et al. Radiologic evaluation of breast disorders related to pregnancy and lactation. Radiographics 2007; 27 Suppl 1:S101.</a></li><li><a class="nounderline abstract_t">Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 1994; 331:10.</a></li><li><a class="nounderline abstract_t">Page DL, Dupont WD, Rogers LW, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 1982; 49:751.</a></li><li><a class="nounderline abstract_t">Ciatto S, Andreoli C, Cirillo A, et al. The risk of breast cancer subsequent to histologic diagnosis of benign intraductal papilloma follow-up study of 339 cases. Tumori 1991; 77:41.</a></li><li><a class="nounderline abstract_t">Marshall LM, Hunter DJ, Connolly JL, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 1997; 6:297.</a></li><li><a class="nounderline abstract_t">Woods ER, Helvie MA, Ikeda DM, et al. Solitary breast papilloma: comparison of mammographic, galactographic, and pathologic findings. AJR Am J Roentgenol 1992; 159:487.</a></li><li><a class="nounderline abstract_t">Jaffer S, Bleiweiss IJ, Nagi C. Incidental intraductal papillomas (&lt;2 mm) of the breast diagnosed on needle core biopsy do not need to be excised. Breast J 2013; 19:130.</a></li><li><a class="nounderline abstract_t">Lewis JT, Hartmann LC, Vierkant RA, et al. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol 2006; 30:665.</a></li><li><a class="nounderline abstract_t">Valdes EK, Feldman SM, Boolbol SK. Papillary lesions: a review of the literature. Ann Surg Oncol 2007; 14:1009.</a></li><li><a class="nounderline abstract_t">Mercado CL, Hamele-Bena D, Oken SM, et al. Papillary lesions of the breast at percutaneous core-needle biopsy. Radiology 2006; 238:801.</a></li><li><a class="nounderline abstract_t">Sydnor MK, Wilson JD, Hijaz TA, et al. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. Radiology 2007; 242:58.</a></li><li><a class="nounderline abstract_t">Ahmadiyeh N, Stoleru MA, Raza S, et al. Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome. Ann Surg Oncol 2009; 16:2264.</a></li><li><a class="nounderline abstract_t">Wen X, Cheng W. Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors. Ann Surg Oncol 2013; 20:94.</a></li><li><a class="nounderline abstract_t">Renshaw AA, Derhagopian RP, Tizol-Blanco DM, Gould EW. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. Am J Clin Pathol 2004; 122:217.</a></li><li><a class="nounderline abstract_t">Agoff SN, Lawton TJ. Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy? Am J Clin Pathol 2004; 122:440.</a></li><li><a class="nounderline abstract_t">Sohn V, Keylock J, Arthurs Z, et al. Breast papillomas in the era of percutaneous needle biopsy. Ann Surg Oncol 2007; 14:2979.</a></li><li><a class="nounderline abstract_t">Moseley T, Desai B, Whitman GJ, et al. Benign Breast Intraductal Papillomas Without Atypia at Core Needle Biopsies: Is Surgical Excision Necessary? Ann Surg Oncol 2021; 28:1347.</a></li><li><a class="nounderline abstract_t">Nakhlis F, Ahmadiyeh N, Lester S, et al. Papilloma on core biopsy: excision vs. observation. Ann Surg Oncol 2015; 22:1479.</a></li><li><a class="nounderline abstract_t">Khan S, Diaz A, Archer KJ, et al. Papillary lesions of the breast: To excise or observe? Breast J 2018; 24:350.</a></li><li><a class="nounderline abstract_t">Symbol B, Ricci A Jr. Management of intraductal papilloma without atypia of the breast diagnosed on core biopsy: Size and sampling matter. Breast J 2018; 24:738.</a></li><li><a class="nounderline abstract_t">Ahn SK, Han W, Moon HG, et al. Management of benign papilloma without atypia diagnosed at ultrasound-guided core needle biopsy: Scoring system for predicting malignancy. Eur J Surg Oncol 2018; 44:53.</a></li><li><a class="nounderline abstract_t">Foley NM, Racz JM, Al-Hilli Z, et al. An International Multicenter Review of the Malignancy Rate of Excised Papillomatous Breast Lesions. Ann Surg Oncol 2015; 22 Suppl 3:S385.</a></li><li><a class="nounderline abstract_t">Nakhlis F, Baker GM, Pilewskie M, et al. The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034). Ann Surg Oncol 2021; 28:2573.</a></li><li class="breakAll">American Society of Breast Surgeons. Official statement. Consensus guideline on concordance assessment of image-guided breast biopsies and management of borderline or high-risk lesions. 2016. Available at: https://www.breastsurgeons.org/docs/statements/Consensus-Guideline-on-Concordance-Assessment-of-Image-Guided-Breast-Biopsies.pdf (Accessed on April 29, 2020).</li><li><a class="nounderline abstract_t">Ali-Fehmi R, Carolin K, Wallis T, Visscher DW. Clinicopathologic analysis of breast lesions associated with multiple papillomas. Hum Pathol 2003; 34:234.</a></li><li><a class="nounderline abstract_t">Ueng SH, Mezzetti T, Tavassoli FA. Papillary neoplasms of the breast: a review. Arch Pathol Lab Med 2009; 133:893.</a></li><li class="breakAll">Haagensen CD. Multiple intraductal papilloma. In: Disease of the Breast, 3rd ed, Haagensen CD (Ed), WB Saunders, Philadelphia 1986. p.176.</li><li><a class="nounderline abstract_t">Murad TM, Contesso G, Mouriesse H. Papillary tumors of large lactiferous ducts. Cancer 1981; 48:122.</a></li><li><a class="nounderline abstract_t">Wang J, Costantino JP, Tan-Chiu E, et al. Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst 2004; 96:616.</a></li><li><a class="nounderline abstract_t">Jensen RA, Page DL, Dupont WD, Rogers LW. Invasive breast cancer risk in women with sclerosing adenosis. Cancer 1989; 64:1977.</a></li><li><a class="nounderline abstract_t">Visscher DW, Nassar A, Degnim AC, et al. Sclerosing adenosis and risk of breast cancer. Breast Cancer Res Treat 2014; 144:205.</a></li><li><a class="nounderline abstract_t">Mitnick JS, Vazquez MF, Harris MN, Roses DF. Differentiation of radial scar from scirrhous carcinoma of the breast: mammographic-pathologic correlation. Radiology 1989; 173:697.</a></li><li><a class="nounderline abstract_t">Jacobs TW, Byrne C, Colditz G, et al. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 1999; 340:430.</a></li><li><a class="nounderline abstract_t">Sanders ME, Page DL, Simpson JF, et al. Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer 2006; 106:1453.</a></li><li><a class="nounderline abstract_t">Berg JC, Visscher DW, Vierkant RA, et al. Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat 2008; 108:167.</a></li><li><a class="nounderline abstract_t">Crystal P, Sadaf A, Bukhanov K, et al. High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: can underestimation be predicted? Eur Radiol 2011; 21:582.</a></li><li><a class="nounderline abstract_t">Sohn VY, Causey MW, Steele SR, et al. The treatment of radial scars in the modern era--surgical excision is not required. Am Surg 2010; 76:522.</a></li><li><a class="nounderline abstract_t">Linda A, Zuiani C, Furlan A, et al. Radial scars without atypia diagnosed at imaging-guided needle biopsy: how often is associated malignancy found at subsequent surgical excision, and do mammography and sonography predict which lesions are malignant? AJR Am J Roentgenol 2010; 194:1146.</a></li><li><a class="nounderline abstract_t">Hayes BD, O'Doherty A, Quinn CM. Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience. J Clin Pathol 2009; 62:1136.</a></li><li><a class="nounderline abstract_t">Liberman L. Clinical management issues in percutaneous core breast biopsy. Radiol Clin North Am 2000; 38:791.</a></li><li><a class="nounderline abstract_t">Kennedy M, Masterson AV, Kerin M, Flanagan F. Pathology and clinical relevance of radial scars: a review. J Clin Pathol 2003; 56:721.</a></li><li><a class="nounderline abstract_t">Patterson JA, Scott M, Anderson N, Kirk SJ. Radial scar, complex sclerosing lesion and risk of breast cancer. Analysis of 175 cases in Northern Ireland. Eur J Surg Oncol 2004; 30:1065.</a></li><li><a class="nounderline abstract_t">Bianchi S, Giannotti E, Vanzi E, et al. Radial scar without associated atypical epithelial proliferation on image-guided 14-gauge needle core biopsy: analysis of 49 cases from a single-centre and review of the literature. Breast 2012; 21:159.</a></li><li><a class="nounderline abstract_t">Manfrin E, Remo A, Falsirollo F, et al. Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 cases. Breast Cancer Res Treat 2008; 107:371.</a></li><li><a class="nounderline abstract_t">Leong RY, Kohli MK, Zeizafoun N, et al. Radial Scar at Percutaneous Breast Biopsy That Does Not Require Surgery. J Am Coll Surg 2016; 223:712.</a></li><li><a class="nounderline abstract_t">Li Z, Ranade A, Zhao C. Pathologic findings of follow-up surgical excision for radial scar on breast core needle biopsy. Hum Pathol 2016; 48:76.</a></li><li><a class="nounderline abstract_t">Phantana-Angkool A, Forster MR, Warren YE, et al. Rate of radial scars by core biopsy and upgrading to malignancy or high-risk lesions before and after introduction of digital breast tomosynthesis. Breast Cancer Res Treat 2019; 173:23.</a></li><li><a class="nounderline abstract_t">Farshid G, Buckley E. Meta-analysis of upgrade rates in 3163 radial scars excised after needle core biopsy diagnosis. Breast Cancer Res Treat 2019; 174:165.</a></li><li><a class="nounderline abstract_t">Kraft E, Limberg JN, Dodelzon K, et al. Radial Scars and Complex Sclerosing Lesions of the Breast: Prevalence of Malignancy and Natural History Under Active Surveillance. Ann Surg Oncol 2021; 28:5149.</a></li><li><a class="nounderline abstract_t">Carty NJ, Carter C, Rubin C, et al. Management of fibroadenoma of the breast. Ann R Coll Surg Engl 1995; 77:127.</a></li><li class="breakAll">Radiopaedia. Yonso MOH, Jones J, et al. Fibroadenoma (breast). Available at: https://radiopaedia.org/articles/fibroadenoma-breast?lang=us (Accessed on February 09, 2021).</li><li><a class="nounderline abstract_t">Harvey JA, Nicholson BT, Lorusso AP, et al. Short-term follow-up of palpable breast lesions with benign imaging features: evaluation of 375 lesions in 320 women. AJR Am J Roentgenol 2009; 193:1723.</a></li><li><a class="nounderline abstract_t">Littrup PJ, Freeman-Gibb L, Andea A, et al. Cryotherapy for breast fibroadenomas. Radiology 2005; 234:63.</a></li><li><a class="nounderline abstract_t">Kaufman CS, Bachman B, Littrup PJ, et al. Office-based ultrasound-guided cryoablation of breast fibroadenomas. Am J Surg 2002; 184:394.</a></li><li><a class="nounderline abstract_t">Kaufman CS, Littrup PJ, Freman-Gibb LA, et al. Office-based cryoablation of breast fibroadenomas: 12-month followup. J Am Coll Surg 2004; 198:914.</a></li><li><a class="nounderline abstract_t">Whitworth PW, Rewcastle JC. Cryoablation and cryolocalization in the management of breast disease. J Surg Oncol 2005; 90:1.</a></li><li><a class="nounderline abstract_t">Hung WK, Ying M, Chan CM, et al. Minimally invasive technology in the management of breast disease. Breast Cancer 2009; 16:23.</a></li><li><a class="nounderline abstract_t">Grady I, Gorsuch H, Wilburn-Bailey S. Long-term outcome of benign fibroadenomas treated by ultrasound-guided percutaneous excision. Breast J 2008; 14:275.</a></li><li><a class="nounderline abstract_t">Sklair-Levy M, Sella T, Alweiss T, et al. Incidence and management of complex fibroadenomas. AJR Am J Roentgenol 2008; 190:214.</a></li><li><a class="nounderline abstract_t">Efared B, Sidibé IS, Abdoulaziz S, et al. Tubular Adenoma of the Breast: A Clinicopathologic Study of a Series of 9 Cases. Clin Med Insights Pathol 2018; 11:1179555718757499.</a></li><li><a class="nounderline abstract_t">Sengupta S, Pal S, Biswas BK, et al. Preoperative Diagnosis of Tubular Adenoma of Breast - 10 years of experience. N Am J Med Sci 2014; 6:219.</a></li><li><a class="nounderline abstract_t">Sengupta S, Pal S, Biswas BK, et al. Evaluation of Clinico-Radio-Pathological Features of Tubular Adenoma of Breast: a Study of Ten Cases with Histopathological Differential Diagnosis. Iran J Pathol 2015; 10:17.</a></li><li><a class="nounderline abstract_t">Celliers L, Wong DD, Bourke A. Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features. Clin Radiol 2010; 65:145.</a></li><li><a class="nounderline abstract_t">Hoda SA, Rosen PP. Observations on the pathologic diagnosis of selected unusual lesions in needle core biopsies of breast. Breast J 2004; 10:522.</a></li><li><a class="nounderline abstract_t">Salvador R, Lirola JL, Domínguez R, et al. Pseudo-angiomatous stromal hyperplasia presenting as a breast mass: imaging findings in three patients. Breast 2004; 13:431.</a></li><li><a class="nounderline abstract_t">Hargaden GC, Yeh ED, Georgian-Smith D, et al. Analysis of the mammographic and sonographic features of pseudoangiomatous stromal hyperplasia. AJR Am J Roentgenol 2008; 191:359.</a></li><li><a class="nounderline abstract_t">Gresik CM, Godellas C, Aranha GV, et al. Pseudoangiomatous stromal hyperplasia of the breast: a contemporary approach to its clinical and radiologic features and ideal management. Surgery 2010; 148:752.</a></li><li><a class="nounderline abstract_t">Rao R, Ludwig K, Bailey L, et al. Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely® Campaign. Ann Surg Oncol 2018; 25:2795.</a></li><li><a class="nounderline abstract_t">Morrow M, Schnitt SJ, Norton L. Current management of lesions associated with an increased risk of breast cancer. Nat Rev Clin Oncol 2015; 12:227.</a></li><li><a class="nounderline abstract_t">Taboada JL, Stephens TW, Krishnamurthy S, et al. The many faces of fat necrosis in the breast. AJR Am J Roentgenol 2009; 192:815.</a></li><li><a class="nounderline abstract_t">Soo MS, Kornguth PJ, Hertzberg BS. Fat necrosis in the breast: sonographic features. Radiology 1998; 206:261.</a></li><li><a class="nounderline abstract_t">Agochukwu NB, Wong L. Diabetic Mastopathy: A Systematic Review of Surgical Management of a Rare Breast Disease. Ann Plast Surg 2017; 78:471.</a></li><li><a class="nounderline abstract_t">Thorncroft K, Forsyth L, Desmond S, Audisio RA. The diagnosis and management of diabetic mastopathy. Breast J 2007; 13:607.</a></li><li><a class="nounderline abstract_t">Weinstein SP, Conant EF, Orel SG, et al. Diabetic mastopathy in men: imaging findings in two patients. Radiology 2001; 219:797.</a></li><li><a class="nounderline abstract_t">Lammie GA, Bobrow LG, Staunton MD, et al. Sclerosing lymphocytic lobulitis of the breast--evidence for an autoimmune pathogenesis. Histopathology 1991; 19:13.</a></li><li><a class="nounderline abstract_t">Guzik P, Gęca T, Topolewski P, et al. Diabetic Mastopathy. Review of Diagnostic Methods and Therapeutic Options. Int J Environ Res Public Health 2021; 19.</a></li><li><a class="nounderline abstract_t">Rajasundaram S, Vijayakumar V, Chegu D, et al. Diabetic mastopathy-An uncommon presentation of a common disease. Breast J 2020; 26:1409.</a></li><li><a class="nounderline abstract_t">Nasser HA, Assaf S, Aouad G, et al. Breast manifestations of type I diabetes mellitus. Breast J 2020; 26:2079.</a></li><li class="breakAll">Lester SC, Hicks DG. Diagnostic Pathology: Breast, 2nd ed, Elsevier, 2016. p.530.</li><li><a class="nounderline abstract_t">Andrews-Tang D, Diamond AB, Rogers L, Butler D. Diabetic Mastopathy: Adjunctive Use of Ultrasound and Utility of Core Biopsy in Diagnosis. Breast J 2000; 6:183.</a></li><li><a class="nounderline abstract_t">Lai EC, Chan WC, Ma TK, et al. The role of conservative treatment in idiopathic granulomatous mastitis. Breast J 2005; 11:454.</a></li><li><a class="nounderline abstract_t">Gombos EC, Esserman LE, Weisberg S, et al. Granulomatous mastitis. J Women's Imaging 2004; 6:136.</a></li><li><a class="nounderline abstract_t">Kudva YC, Reynolds C, O'Brien T, et al. "Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes. Diabetes Care 2002; 25:121.</a></li><li><a class="nounderline abstract_t">Kim J, Kim EK, Kim MJ, et al. Diabetic mastopathy: imaging features and the role of image-guided biopsy in its diagnosis. Ultrasonography 2016; 35:140.</a></li><li><a class="nounderline abstract_t">Sankaye S, Kachewar S. Diabetic mastopathy. Australas Med J 2012; 5:296.</a></li><li><a class="nounderline abstract_t">Shrikrishnapalasuriyar N, Atkinson M, Kalhan A, et al.. Diabetic mastopathy: A diagnostic challenge. Br J Diabetes 2018; 18:32.</a></li><li><a class="nounderline abstract_t">Tse GM, Law BK, Ma TK, et al. Hamartoma of the breast: a clinicopathological review. J Clin Pathol 2002; 55:951.</a></li><li><a class="nounderline abstract_t">Sevim Y, Kocaay AF, Eker T, et al. Breast hamartoma: a clinicopathologic analysis of 27 cases and a literature review. Clinics (Sao Paulo) 2014; 69:515.</a></li><li><a class="nounderline abstract_t">Mahmoud W, El Ansari W, Hassan S, et al. Giant mammary hamartoma in a middle aged female. Case report and review of literature of the last 15 years. Int J Surg Case Rep 2021; 78:145.</a></li><li><a class="nounderline abstract_t">Sabaté JM, Clotet M, Gómez A, et al. Radiologic evaluation of uncommon inflammatory and reactive breast disorders. Radiographics 2005; 25:411.</a></li><li><a class="nounderline abstract_t">Lower EE, Hawkins HH, Baughman RP. Breast disease in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18:301.</a></li></ol></div><div id="topicVersionRevision">Topic 806 Version 30.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34170304" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34136908" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Physical activity and risk of benign proliferative epithelial disorders of the breast, in the Women's Health Initiative.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12766590" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Benign breast disease and breast cancer risk: morphology and beyond.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1734106" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : A prospective study of benign breast disease and the risk of breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3965932" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Risk factors for breast cancer in women with proliferative breast disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16034008" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Benign breast disease and the risk of breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16034008" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Benign breast disease and the risk of breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16720843" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Benign breast diseases: classification, diagnosis, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16900392" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Benign breast diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3606334" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Is 'fibrocystic disease' of the breast precancerous?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2205361" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Anatomic markers of human premalignancy and risk of breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17319851" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7110289" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Sounding board. Fibrocystic "disease" of the breast--a nondisease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18180221" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Radiologic evaluation of breast disorders related to pregnancy and lactation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8202095" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Long-term risk of breast cancer in women with fibroadenoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6275978" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Intraductal carcinoma of the breast: follow-up after biopsy only.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2017798" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The risk of breast cancer subsequent to histologic diagnosis of benign intraductal papilloma follow-up study of 339 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9149887" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1503011" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Solitary breast papilloma: comparison of mammographic, galactographic, and pathologic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23336823" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Incidental intraductal papillomas (&lt;2 mm) of the breast diagnosed on needle core biopsy do not need to be excised.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16723843" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : An analysis of breast cancer risk in women with single, multiple, and atypical papilloma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17206486" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Papillary lesions: a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16424237" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Papillary lesions of the breast at percutaneous core-needle biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17090707" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19484312" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22878621" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15323138" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15362376" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17549566" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Breast papillomas in the era of percutaneous needle biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32860176" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Benign Breast Intraductal Papillomas Without Atypia at Core Needle Biopsies: Is Surgical Excision Necessary?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25361885" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Papilloma on core biopsy: excision vs. observation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28845569" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Papillary lesions of the breast: To excise or observe?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29687535" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Management of intraductal papilloma without atypia of the breast diagnosed on core biopsy: Size and sampling matter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29174198" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Management of benign papilloma without atypia diagnosed at ultrasound-guided core needle biopsy: Scoring system for predicting malignancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26240010" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : An International Multicenter Review of the Malignancy Rate of Excised Papillomatous Breast Lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33047246" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33047246" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12673557" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Clinicopathologic analysis of breast lesions associated with multiple papillomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19492881" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Papillary neoplasms of the breast: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19492881" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Papillary neoplasms of the breast: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7195300" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Papillary tumors of large lactiferous ducts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15100339" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Lower-category benign breast disease and the risk of invasive breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2804888" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Invasive breast cancer risk in women with sclerosing adenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24510013" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Sclerosing adenosis and risk of breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2554361" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Differentiation of radial scar from scirrhous carcinoma of the breast: mammographic-pathologic correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9971867" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Radial scars in benign breast-biopsy specimens and the risk of breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16502407" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18297395" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Breast cancer risk in women with radial scars in benign breast biopsies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20839000" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: can underestimation be predicted?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20506884" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The treatment of radial scars in the modern era--surgical excision is not required.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20308524" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Radial scars without atypia diagnosed at imaging-guided needle biopsy: how often is associated malignancy found at subsequent surgical excision, and do mammography and sonography predict which lesions are malignant?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19946101" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10943278" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Clinical management issues in percutaneous core breast biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14514771" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Pathology and clinical relevance of radial scars: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15522552" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Radial scar, complex sclerosing lesion and risk of breast cancer. Analysis of 175 cases in Northern Ireland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21944431" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Radial scar without associated atypical epithelial proliferation on image-guided 14-gauge needle core biopsy: analysis of 49 cases from a single-centre and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17457669" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27542917" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Radial Scar at Percutaneous Breast Biopsy That Does Not Require Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26772402" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Pathologic findings of follow-up surgical excision for radial scar on breast core needle biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30242581" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Rate of radial scars by core biopsy and upgrading to malignancy or high-risk lesions before and after introduction of digital breast tomosynthesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30460464" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Meta-analysis of upgrade rates in 3163 radial scars excised after needle core biopsy diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33666811" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Radial Scars and Complex Sclerosing Lesions of the Breast: Prevalence of Malignancy and Natural History Under Active Surveillance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7793802" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Management of fibroadenoma of the breast.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7793802" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Management of fibroadenoma of the breast.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19933671" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Short-term follow-up of palpable breast lesions with benign imaging features: evaluation of 375 lesions in 320 women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15550369" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Cryotherapy for breast fibroadenomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12433600" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Office-based ultrasound-guided cryoablation of breast fibroadenomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15194073" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Office-based cryoablation of breast fibroadenomas: 12-month followup.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15786430" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Cryoablation and cryolocalization in the management of breast disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18818988" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Minimally invasive technology in the management of breast disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18397185" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Long-term outcome of benign fibroadenomas treated by ultrasound-guided percutaneous excision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18094314" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Incidence and management of complex fibroadenomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29449780" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Tubular Adenoma of the Breast: A Clinicopathologic Study of a Series of 9 Cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24926447" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Preoperative Diagnosis of Tubular Adenoma of Breast - 10 years of experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26516321" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Evaluation of Clinico-Radio-Pathological Features of Tubular Adenoma of Breast: a Study of Ten Cases with Histopathological Differential Diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20103437" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15569209" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Observations on the pathologic diagnosis of selected unusual lesions in needle core biopsies of breast.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15454202" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Pseudo-angiomatous stromal hyperplasia presenting as a breast mass: imaging findings in three patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18647902" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Analysis of the mammographic and sonographic features of pseudoangiomatous stromal hyperplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20708765" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Pseudoangiomatous stromal hyperplasia of the breast: a contemporary approach to its clinical and radiologic features and ideal management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29968026" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely®Campaign.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25622978" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Current management of lesions associated with an increased risk of breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19234281" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : The many faces of fat necrosis in the breast.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9423681" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Fat necrosis in the breast: sonographic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28272124" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Diabetic Mastopathy: A Systematic Review of Surgical Management of a Rare Breast Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17983405" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : The diagnosis and management of diabetic mastopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11376272" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Diabetic mastopathy in men: imaging findings in two patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1916685" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Sclerosing lymphocytic lobulitis of the breast--evidence for an autoimmune pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35010708" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Diabetic Mastopathy. Review of Diagnostic Methods and Therapeutic Options.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31908050" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Diabetic mastopathy-An uncommon presentation of a common disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32557952" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Breast manifestations of type I diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32557952" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Breast manifestations of type I diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11348362" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Diabetic Mastopathy: Adjunctive Use of Ultrasound and Utility of Core Biopsy in Diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16297091" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : The role of conservative treatment in idiopathic granulomatous mastitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Granulomatous mastitis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11772912" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : "Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26810194" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Diabetic mastopathy: imaging features and the role of image-guided biopsy in its diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22848327" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Diabetic mastopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Diabetic mastopathy: A diagnostic challenge</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12461066" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Hamartoma of the breast: a clinicopathological review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25141109" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Breast hamartoma: a clinicopathologic analysis of 27 cases and a literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33360331" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Giant mammary hamartoma in a middle aged female. Case report and review of literature of the last 15 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15798059" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Radiologic evaluation of uncommon inflammatory and reactive breast disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11587103" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Breast disease in sarcoidosis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
